MoneyWorks4Me

USFDA issues EIR to Piramal Pharma’s USA facility

16 Feb 2023 Evaluate

The United States Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for Piramal Pharma’s manufacturing facility located at Lexington (Kentucky, USA). The inspection has now been successfully closed by the USFDA.

Piramal Pharma (PPL) offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries.

Peers
Company Name CMP
Sun Pharma. Inds. 1846.30
Dr. Reddys Labs. 1221.50
Cipla 1392.30
Lupin 2071.65
Zydus Lifesciences 1213.10
View more..